claim: dana-farber to test breast cancer drug in covid-19 patients
evidence_1: dana-farber will collaborate with the study sponsor to carry out corollary studies to understand how the immune system functions in covid-19 patients and how the addition of btk-inhibitors can stop immune over-activity in response to the virus.